PNKD anticorps
-
- Antigène Voir toutes PNKD Anticorps
- PNKD (Paroxysmal Nonkinesigenic Dyskinesia (PNKD))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PNKD est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Fusion protein of human PNKD
- Isotype
- IgG
- Top Product
- Discover our top product PNKD Anticorps primaire
-
-
- Indications d'application
- IHC 1:40-1:200, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.14 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- PNKD (Paroxysmal Nonkinesigenic Dyskinesia (PNKD))
- Autre désignation
- PNKD (PNKD Produits)
- Synonymes
- anticorps BRP17, anticorps DYT8, anticorps FPD1, anticorps KIPP1184, anticorps MR-1, anticorps MR1, anticorps PDC, anticorps PKND1, anticorps TAHCCP2, anticorps 2210013N15Rik, anticorps 2810403H05Rik, anticorps AI854243, anticorps Brp17, anticorps MNCb-5687, anticorps Tahccp2, anticorps paroxysmal nonkinesigenic dyskinesia, anticorps paroxysmal nonkinesiogenic dyskinesia, anticorps PNKD, anticorps Pnkd
- Sujet
- This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants.
- UniProt
- Q8N490
-